Company profile
Target Group Inc.
OTC: CBDY · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Hamilton, ONCIK 0001586554Reports USD
#726 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
46DFH 41DQ 61GM 32SS 42
v0.1 · 65/100 weight · provisional
↑ filing timeliness, return on assets · ↓ balance-sheet leverage, revenue growth (YoY)
Methodology →Revenue TTM
$3.4M
Rev growth YoY (TTM)
-44.4%
Net income (FY)
-$1.4M
Employees
40
as of 2026-08-26
Market cap
$555.3k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$3.9M$3.9M2025
Net income-$1.4M-$1.4M2025
Total assets$6.2M$6.2M2025
Liabilities$14.2M$14.2M2025
Equity-$8.1M-$8.1M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY22
FY23
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Target Group Inc.’s revenue?
Target Group Inc. booked $3.9M in FY2025 revenue, contracting 41% year over year — slower than 79% of Healthcare companies we track, at a -35.0% net margin.
Peers · Healthcare
CervoMed Inc.42DTenon Medical, Inc.35DNovaBridge Biosciences36DEVIO, Inc.——Cibus, Inc.43DNeurAxis, Inc.45DKey facts
CEOAnthony Carlo Zarcone
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersHamilton, ON
ExchangeOTC: CBDY
Employees40
IPO date2015-12-28
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.